Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03170583 · ClinicalTrials.gov registry record
SJM Brady MRI Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Terminated
- Registry status
- 1,768
- Enrollment target
NCT03170583: Clinical Trial study, sponsored by Abbott Medical Devices.
NCT03170583 is a clinical trial that was terminated before completion, run by Abbott Medical Devices. The registered enrollment target is 1,768 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03170583 was terminated before completion, sponsored by Abbott Medical Devices.
- TERMINATED
- Registry status
- 1,768 participants
- Enrollment target
Study Summary
The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System) in subjects with a standard bradycardia pacing indication.
Interventions
- DEVICE St. Jude Medical Tendril MRI™ lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,768 participants |
| Start Date | 2017-06-08 |
| Est. Completion | 2020-06-30 |
Why NCT03170583 stopped before completion
NCT03170583 is an observational study that tracks outcomes without assigning an intervention. Its 1,768 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which St. Jude Medical Tendril MRI™ lead is the first listed.
NCT03170583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03170583 about?
NCT03170583 is a clinical study titled "SJM Brady MRI Post Approval Study". The purpose of this post approval study is to evaluate the long-term safety of the FDA approved St. Jude Medical Tendril MRI™ lead implanted with a SJM Brady MRI implantable pulse generator (IPG) such as the Accent MRI™, Assurity MRI™, Endurity MRI™ pacemaker, or similar model (SJM Brady MRI System)...
What is the current status of trial NCT03170583?
This trial is currently terminated. The enrollment target is 1,768 participants. The study started on 2017-06-08. Estimated completion is 2020-06-30.
What interventions are being tested in trial NCT03170583?
The interventions under investigation include: St. Jude Medical Tendril MRI™ lead (DEVICE).
Who is sponsoring clinical trial NCT03170583?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT03067181 · 1,780 participants · Phase 3
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- NCT06526650 · 1,780 participants · NA
'Ai Pono Cooking Demonstrations
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI